Uncategorized
Approaching the macula from the premium cataract surgeon perspective
Premium cataract surgeons face the daily decision of whether to offer cataract surgery patients the option of multifocal IOL or other advanced IOL technology, which could contribute to current and/or future potential undesirable visual aberrations postoperatively. Patients may present at their initial cataract evaluation with a pristine macula or early pathology such as an epiretinal membrane or mild macular degeneration. Even with a normal macula, the potential for macular pathology in the future is essentially unknown without specialized diagnostic approaches to improve our detection and/or prediction odds. The decision to (Read more...)